Radius Health, Inc. (RDUS) financial statements (2022 and earlier)

Company profile

Business Address ATTN: PRINCIPAL FINANCE OFFICER
BOSTON, MA 02210
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:112115161237430332473
Cash and cash equivalents112917059119259160
Short-term investments 4718235413574314
Other undisclosed cash, cash equivalents, and short-term investments(0)(23)(91)(177)177(0)(0)
Restricted cash and investments    00 
Receivables232023174  
Inventory, net of allowances, customer advances and progress billings119564  
Inventory119564  
Prepaid expense101312145  
Other current assets1623112  
Other undisclosed current assets1111(177)27
Total current assets:173181203275270335480
Noncurrent Assets
Operating lease, right-of-use asset147
Property, plant and equipment1124652
Long-term investments and receivables    177  
Long-term investments    177  
Intangible assets, net (including goodwill)56778  
Intangible assets, net (excluding goodwill)56778  
Other noncurrent assets2111110
Total noncurrent assets:811161219252
TOTAL ASSETS:182192219287462340482
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities94705946533321
Accounts payable181064466
Accrued liabilities77605342502715
Deferred revenue 1 
Debt  2    
Other undisclosed current liabilities12     
Total current liabilities:95736146533321
Noncurrent Liabilities
Long-term debt and lease obligation045    
Operating lease, liability045
Liabilities, other than long-term debt   000 
Other liabilities   000 
Other undisclosed noncurrent liabilities338235196180166  
Total noncurrent liabilities:3392422001801660 
Total liabilities:4343152612262203321
Stockholders' equity
Stockholders' equity attributable to parent(252)(124)(42)61242307461
Common stock0000000
Additional paid in capital1,1161,2221,1941,1651,125936907
Accumulated other comprehensive income (loss) 00(1)(0)00
Accumulated deficit(1,368)(1,346)(1,237)(1,104)(882)(629)(446)
Total stockholders' equity:(252)(124)(42)61242307461
TOTAL LIABILITIES AND EQUITY:182192219287462340482

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues230239  22  
Revenue, net22  
Cost of revenue
(Cost of Goods and Services Sold)
(19)(17)(16)(8)(0)  
Gross profit:211221(16)(8)22  
Operating expenses(265)(304)(269)(295)(270)(185)(99)
Other undisclosed operating income (loss)  17398(1)  
Operating loss:(54)(82)(112)(204)(249)(185)(99)
Nonoperating income0146321
Investment income, nonoperating0146321
Other nonoperating income (expense)0(0)00(0)(0)(0)
Interest and debt expense(16)(28)(25)(23)(8) (3)
Net loss available to common stockholders, diluted:(70)(109)(133)(221)(254)(183)(102)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(70)(109)(133)(221)(254)(183)(102)
Comprehensive loss:(70)(109)(133)(221)(254)(183)(102)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)01(0)(0)00
Comprehensive loss, net of tax, attributable to parent:(70)(109)(132)(222)(255)(183)(102)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: